Hi Cato!Hi Kervio
This is the post with the best modelling in it - https://hotcopper.com.au/threads/overwhelming-efficacy-the-stats-required.5579134
There's some chance at the 60% readout of overwhelming efficacy but it mostly depends on the mortality rate of the control group. If lots of them died then it's easier to show efficacy.
I'll reproduce the 60% table here for those that don't like clicking:
60% Readout
35% 40% 50% 60% 65% 70% 75% 80% 85% 15% skeptical 0.373 0.511 0.742 0.895 0.942 0.973 0.990 0.997 0.999 15% uninformed 0.932 0.985 0.999 0.999 0.999 0.999 0.999 0.999 0.999 20% skeptical 0.188 0.303 0.545 0.757 0.841 0.907 0.953 0.981 0.994 20% uninformed 0.708 0.890 0.992 0.999 0.999 0.999 0.999 0.999 0.999
In my best guess, we should be reading the row for "15% skeptical", so a control mortality of 70% or over may end the trial early.
biggest caveats:
- we don't know the prior in use (which does affect the result a lot)
- we don't know the treatment effect rate, though I assumed here it's the same as the EUA data)
Enjoy!
I believe S.I. stated that the mortality rate is (probably an average of) 60% for those 60 and above. He further stated that they are enrolling people regardless of age and some people are younger, hence the 'average' mortality rate must be less than 60%. I imagine it is somewhere between 40 and 50% (no reason, just my surmise). In which case if we are using a '15% skeptical' we will not get an early end to the trial.
Does my reasoning seem reasonable to you?
- Forums
- ASX - By Stock
- MSB
- Guess the opening price - if ARDS halted due supreme efficacy
MSB
mesoblast limited
Add to My Watchlist
0.61%
!
$1.66

Guess the opening price - if ARDS halted due supreme efficacy, page-216
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.66 |
Change
0.010(0.61%) |
Mkt cap ! $2.114B |
Open | High | Low | Value | Volume |
$1.66 | $1.69 | $1.64 | $5.790M | 3.482M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 460 | $1.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 67181 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 460 | 1.655 |
1 | 30000 | 1.650 |
1 | 30000 | 1.645 |
1 | 4685 | 1.640 |
3 | 21682 | 1.630 |
Price($) | Vol. | No. |
---|---|---|
1.660 | 61181 | 4 |
1.665 | 1801 | 1 |
1.670 | 20000 | 1 |
1.675 | 19642 | 2 |
1.680 | 31450 | 4 |
Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
VMM
VIRIDIS MINING AND MINERALS LIMITED
Rafael Moreno, CEO
Rafael Moreno
CEO
SPONSORED BY The Market Online